Curve Therapeutics Is A Biotechnology Company Based In Southamptonukfounded In 2019The Company Specializes In Drug Discovery And Development Using Its Proprietary Microcycleaplatformthis Innovative Platform Focuses On Addressing Challenging Intracellular Targets In Oncology And Immunology Through Small Molecule Therapeutics Curve Therapeutics Is Currently In The Series A Funding Stagehaving Raised A Total Of $54 35 Millionincluding A Significant Series A Round Led By Pfizer Venturesthe Microcycleaplatform Enables The Functional Screening Of Small Molecule Libraries Within Live Mammalian Cellsallowing For The Identification Of Biologically Active Compounds Against Complex Targetsthe Company Is Advancing A Preclinical Pipeline That Includes A Hif 1 2 Dual Inhibitor And An Atic Dimerization Inhibitorboth Aimed At High Need Oncology Indicationscurve Therapeutics Collaborates With Notable Investors And Academic Partners To Support Its Research And Development Efforts
